Compare AU

Compare DRUG vs. MICH

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the Magellan Infrastructure Fund (Currency Hedged)(Managed Fund) (MICH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

MICH

Popularity

Low

Low

Pearlers invested

63

13

Median incremental investment

$990.50

$1,068.57

Median investment frequency

Monthly

Monthly

Median total investment

$1,910.37

$1,538.46

Average age group

26 - 35

> 35


Key Summary

DRUG

MICH

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

MICH.AX was created on 2016-07-19 by Magellan. The fund's investment portfolio concentrates primarily on theme equity. To achieve attractive risk adjusted returns over the medium to long-term, While reducing the risk of permanent capital loss

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Aena SME SA (6.97 %)

Ferrovial SE (6.23 %)

Vinci SA (5.87 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Industrials (46.99 %)

Utilities (45.11 %)

Other (7.90 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

United States (38.21 %)

Spain (15.62 %)

United Kingdom of Great Britain and Northern Ireland (14.04 %)

Management fee

0.57 %

1.05 %


Key Summary

DRUG

MICH

Issuer

BetaShares

Magellan

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

S&P Global Infrastructure Hedged to USD Index

Asset class

ETF

ETF

Management fee

0.57 %

1.05 %

Price

$8.27

$2.94

Size

$182.401 million

N/A

10Y return

N/A

N/A

Annual distribution yield (5Y)

1.90 %

4.12 %

Market

ASX

ASX

First listed date

08/08/2016

22/07/2016

Purchase fee

$6.50

$6.50


Community Stats

DRUG

MICH

Popularity

Low

Low

Pearlers invested

63

13

Median incremental investment

$990.50

$1,068.57

Median investment frequency

Monthly

Monthly

Median total investment

$1,910.37

$1,538.46

Average age group

26 - 35

> 35


Pros and Cons

DRUG

MICH

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher exposure to AU market

  • Higher distribution yield

Cons

  • Lower exposure to AU market

  • Lower distribution yield

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

DRUG

MICH

Lower exposure to AU market

Higher exposure to AU market

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home